PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 60 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q2 2019. The put-call ratio across all filers is 20.98 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $28,000 | -61.6% | 21,866 | -3.1% | 0.00% | – |
| Q4 2018 | $73,000 | +78.0% | 22,574 | +32.9% | 0.00% | – |
| Q3 2018 | $41,000 | -10.9% | 16,981 | +3.6% | 0.00% | – |
| Q2 2018 | $46,000 | +48.4% | 16,395 | +313.6% | 0.00% | – |
| Q1 2017 | $31,000 | -31.1% | 3,964 | +8.9% | 0.00% | – |
| Q4 2016 | $45,000 | -99.9% | 3,641 | -0.3% | 0.00% | – |
| Q3 2016 | $56,919,000 | +28.7% | 3,651 | +0.1% | 0.00% | – |
| Q2 2016 | $44,226,000 | – | 3,646 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 3,804,027 | $46,637,000 | 6.29% |
| NEA Management Company, LLC | 3,556,778 | $43,606,000 | 1.73% |
| Opaleye Management Inc. | 150,000 | $1,839,000 | 1.08% |
| Rock Springs Capital Management LP | 450,000 | $5,517,000 | 0.37% |
| Hillhouse Capital Management | 865,923 | $10,616,000 | 0.24% |
| Eventide Asset Management | 220,000 | $2,697,000 | 0.18% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 186,000 | $2,280,000 | 0.09% |
| Virtus ETF Advisers LLC | 24,169 | $296,000 | 0.09% |
| TFS CAPITAL LLC | 20,078 | $246,000 | 0.07% |
| Trexquant Investment LP | 19,600 | $240,000 | 0.04% |